You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Lps-induced inflammation alters the disposition of fexofenadine in the isolated perfused rat liver.
- In: SIG Bioavailability / Bioequivalence - Poster Session
- At: Cairo (Egypt) (2005)
- Type: Poster
- Poster code: BB-P-005
- By: DAVEY, Andrew (University of South Australia, Centre for Pharmaceutical Research, Adelaide, Australia)
- Co-author(s): Tong (University of South Australia, ADELAIDE, Australia)
Zhang (University of South Australia, ADELAIDE, Australia)
Ngo (University of South Australia, ADELAIDE, Australia) - Abstract:
AIM: To examine the effect of bacterial lipopolysaccharide (LPS) on the pharmacokinetics of fexofenadine (an OATP and P-gp substrate) in the isolated perfused liver. METHODS: Male SD rats were divided into 4 groups (n=4): 1 control group and 3 treatment groups. Inflammation was induced in the 3 treatment groups by either 5, 2.5 or 1mg/kg i.p. of..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026